Autoimmune Diseases · 2011 · 34 citations · 42 references
Life SciencesImmunologyPathologyAutoimmunityClinical ImmunologyImmunopathologyAntigen Detection AssaysAutoantibodiesAutoimmune Disease DiagnosticsAutoimmune DiseasesAnti-myeloperoxidase AntibodiesAnti-neutrophil Cytoplasmic AntibodiesAnti-neutrophil Cytoplasmic Antibody TestingAntineutrophil AntibodiesAntineutrophil Cytoplasmic AntibodiesAntinuclear Antibody PositivityImmunofluorescence DiagnosisIndirect Immunofluorescence Assay
Objective. To retrospectively evaluate ANCA testing in a cohort of unselected Greek in- and outpatients. Methods. In 10803 consecutive serum samples, ANCA were tested by indirect immunofluorescence (IIF) and ELISA. ELISA in inpatients was performed only on IIF positive sera. Results. Low prevalence (6.0%) of IIF positive samples was observed. Among these samples, 63.5% presented perinuclear (p-ANCA), 9.3% cytoplasmic (c-ANCA) and 27.2% atypical (x-ANCA) pattern. 16.1% of p-ANCA were antimyeloperoxidase (anti-MPO) positive, whereas 68.3% of c-ANCA were antiproteinase-3 (anti-PR3) positive. Only 17 IIF negative outpatients' samples were ELISA positive. ANCA-associated vasculitides (AAV), connective tissue disorders and gastrointestinal disorders represented 20.5%, 23.9%, and 21.2% of positive results, respectively. AAV patients exhibited higher rates of MPO/PR3 specificity compared to non-AAV (93.8% versus 8%). Conclusions. This first paper on Greek patients supports that screening for ANCA by IIF and confirming positive results by ELISA minimize laboratory charges without sacrificing diagnostic accuracy.
42
Criteria for diagnosis of Behçet's disease
B Weichsler, Fereydoun Davatchi, Thomas Lehner et al. · The Lancet · 1990 · 3.1K citations